Rangers GM Jon Daniels cast doubt on the idea of the team making any marquee additions in comments yesterday to the media, including MLB.com’s TR Sullivan. Daniels called it “unlikely” that the club would end up with a top starter, though he said he also wouldn’t “close the door” on a market that includes former ace Yu Darvish. More likely, it seems, would be a depth addition of some kind, though Daniels also emphasized that the organization is not close to any new deals. Broadly, the organization remains steadfast in its “realistic” assessment of its abilities and needs. While the anticipated roster mix is likely “to create some challenges,” says Daniels, that doesn’t mean it will vary from its strategy entering the winter. The Rangers, he says, were “not going to go all-in, spending big dollars this year, nor were we going to be looking to trade all of our young players.”
More from the American League:
- The Angels received some promising news on righty J.C. Ramirez, GM Billy Eppler tells Jeff Fletcher of the Orange County Register (via Twitter). Ramirez is continuing to show healing in his right elbow, where he suffered a season-ending partial UCL tear. Stem cell treatment has been promising to this point, giving the team some renewed confidence that it will receive a contribution again from Ramirez, who agreed to a $1.9MM arbitration salary after turning in 147 1/3 innings of 4.15 ERA ball in 2017.
- As the Red Sox prepare for an arbitration show-down with star outfielder Mookie Betts, Michael Silverman of the Boston Herald argues the team never should have put itself in this position. The sides have a $3MM gap at present ($10.5MM vs. $7.5MM) and indications are they’ll resolve it in a hearing, meaning the Sox will be put in the position of presenting Betts in a less-than-positive light before an arb panel. With a prior disagreement over his 2017 pre-arb salary, the financial relationship between the sides isn’t exactly off to the most promising start. For what it’s worth, MLBTR contributor and arbitration guru Matt Swartz argued before numbers were exchanged that Betts is likelier to command a first-time arb payday on the lower side of the existing gulf.
- Speaking of arbitration, the Orioles will evidently not commit to going to trial over their remaining cases, per Roch Kubatko of MASNsports.com. Rather the club is still willing to engage in negotiations with both infielder Jonathan Schoop ($9MM filing versus $7.5MM counter) and righty Kevin Gausman ($6.225MM filing versus $5.3MM counter). Whether that’ll mean avoiding a hearing isn’t yet known, but the seeming strategic shift will at least leave remaining room for talks on a few players of quite a bit of importance to the organization’s future.